Visit Booth 8215 from July 13–15 to discover the debut of Beetles Nail Glow, alongside the brand's expansive Stay Shining and Beetles PRO systems featuring nearly 500 SKUs.
LAS VEGAS, July 13, 2026 /PRNewswire/ -- Beetles Gel Polish, a global nail brand known for accessible gel nail solutions and creative color systems, announces the debut of Beetles Nail Glow, its first official collaboration with Pantone®, at Cosmoprof North America Las Vegas 2026. The brand will showcase the collection at Booth 8215 from July 13–15, together with its growing Stay Shining and Beetles PRO product systems.
The presentation marks a key milestone for Beetles Gel Polish as the brand continues to strengthen its presence across color innovation, complete nail systems, retail-ready solutions, and professional salon support.
The Debut of Beetles Nail Glow: A Healing-Led Color Story
As the hero launch of this year's show, Beetles Nail Glow brings Beetles Gel Polish's color expertise together with Pantone's global color authority. Rooted in the concept of healing, the collection translates self-care, calm, and emotional expression into a sensorial color story for modern nail lovers.
The six-shade collection features a HEMA-free, TPO-free, and TMPTA-free formula designed to support a gentler nail experience. It delivers rich one-coat color payoff, smooth self-leveling performance, and an easy-control brush for more even application.
The hero shade, Medative State, is a soft pale blue created to evoke calm, clarity, and gentle renewal. Its name blends the feeling of "meditative" and "sedative," capturing the soothing emotional energy at the heart of the collection.
"Beetles Nail Glow represents an important step in how we think about color," said a Beetles Gel Polish spokesperson. "For us, color is not only about trend or appearance. It is also about emotion, self-care, and the small rituals that help people feel more confident, calm, and connected."
The limited-edition collaboration opens for pre-order on beetlesgel.com on July 13, 2026.
Complete Nail Systems for Retail and Professional Scenarios
In addition to Beetles Nail Glow, Beetles Gel Polish will showcase its core product systems, including Stay Shining and Beetles PRO.
Stay Shining is designed as a full-spectrum nail system for retail accessibility and salon-quality results, supporting consumers across color, care, tools, and at-home nail creation.
Beetles PRO is a premium professional system developed for nail artists and salon environments, with a focus on reliable application, consistent results, and smoother professional workflows.
Together, the three systems reflect Beetles Gel Polish's broader ambition: to support nail lovers and nail professionals with complete, scenario-based solutions across DIY, retail, and professional channels.
A Platform for Brand Growth and Industry Exchange
Cosmoprof North America Las Vegas provides Beetles Gel Polish with a key opportunity to connect directly with retailers, distributors, salon operators, beauty professionals, and industry partners.
At Booth 8215, attendees will be able to experience the debut of Beetles Nail Glow, explore the brand's nearly 500-SKU product showcase, learn more about the Stay Shining and Beetles PRO systems, and receive custom on-site gifts.
The brand welcomes industry attendees to visit the booth and discover how Beetles Gel Polish is expanding its role in color expression, complete nail solutions, and global channel development.
About Beetles Gel Polish
Founded in 2017, Beetles Gel Polish is a global nail brand offering comprehensive nail solutions across retail and professional beauty. The brand's product universe spans gel polish, nail color systems, nail care, press-ons, tools, lamps, nail art supplies, and professional salon products.
Today, Beetles Gel Polish reaches users across more than 30 countries and regions and has built a growing community of more than 18 million users worldwide. Through its expanding online and offline ecosystem, the brand continues to strengthen its presence across North America and global beauty markets.
Learn more at: https://www.beetlesgel.com/pages/blogs
Media Contact
Beetles Gel Polish PR Team
brand@beetlesgel.com
Wholesale Inquiries
Beetles Gel Polish Wholesale Team
wholesale@beetlesgel.com
Learn more about wholesale opportunities at beetlesgel.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Beetles Gel Polish Unveils Its First-Ever Pantone® Collaboration: Beetles Nail Glow at Cosmoprof North America 2026
SAN DIEGO, July 14, 2026 /PRNewswire/ -- Ahead of the BIO International Convention, BIOSeedin Summer Innovation Partnering Summit was successfully held at Wyndham San Diego Bayside, California. Hosted by bioSeedin, the summit's discussion topics were about early-stage innovation assets, late-stage clinical pipelines, business development strategies, M&A trends, multinational collaboration models, and global licensing transactions.
ACROBiosystems participated as a key strategic partner under the theme "Enabling Global Opportunity," working with a broad network of industry partners to build a strategic partnering platform for the globalization of innovation assets. The event gathered more than 200 participants from over 30 countries, creating a highly active environment for business dialogue and partnering discussions.
During the summit, ACROBiosystems set up a dedicated networking lounge to provide attendees with an exclusive space for in-depth discussion, helping turn thought leadership and ideas into tangible collaboration.
As innovative drug development becomes increasingly global, ACROBiosystems is further leveraging its global customer network, technical service capabilities, industry insight, and ecosystem connectivity to advance its role as a global strategic partner for innovation. Through the summit, ACROBiosystems aims to amplify the visibility of high-potential innovation assets and help them gain greater international recognition, deeper industry understanding, and more partnering opportunities during a critical window for the global biopharmaceutical industry.
From winter to summer, ACROBiosystems has continued to advance global innovation partnerships. Following the BIOSeedin Winter Innovation Partnering Summit in San Francisco this January and the BIOSeedin Spring Innovation Partnering Summit in Shanghai this May, the BIOSeedin Summer Innovation Partnering Summit in San Diego further extended this momentum. Besides, ACROBiosystems has also hosted ACRO Innovation Day and the ACRO Innovation Forum in Europe and Shanghai, reinforcing its commitment to empowering the industry and building platforms for innovation exchange.
Looking ahead, ACROBiosystems will continue to work with global partners around its core brand values of "Reliable Quality, Integrated Innovation, and Considerate Service", jointly accelerating the translation of biopharmaceutical innovation into clinical applications and global markets.
Summit Recap
The summit opened with remarks from Ms. Jenny Zhao, Co-founder and CEO of bioSeedin.
And then the summit went on with panels and company presentations, along with one on one partnering session to motivate exchange and precision collaborations.
The panel session split into two parts: the early-stage and late-stage session.
No. 1 Early-Stage Session
The Early-Stage Session featured two panel discussions on licensing, external innovation, and M&A. The first panel brought together executives from Debiopharm, Otsuka Pharmaceutical, Roche/Genentech, AstraZeneca.
Key Takeaways:
- Licensing is not simply an asset transaction, but a strategic tool for translating differentiated science into long-term value.
- Strong biology, high-quality data, translational continuity, and a credible global clinical development plan remain essential to deal execution.
- Deals often stall due to weak biological rationale, unclear patient or biomarker strategies, poor PK/PD or therapeutic windows, and inadequate global development planning.
The second panel was moderated by Kenneth C. Chen, Senior Director of Business Development, US & EU, at bioSeedin, and featured executives from Sun Pharma, Hygieia Pharma, and Servier.
Key Takeaways:
- M&A should support long-term corporate strategy rather than serve as an end goal.
- Companies need to balance acquisitions, strategic investments, and licensing transactions.
- Successful M&A depends on valuation discipline, rigorous due diligence, effective execution, and post-deal integration.
The session also included company presentations from Antengene, GeneScience Pharmaceutical, and Salsola Therapeutics, showcasing innovative pipelines across autoimmune diseases, immunology, and neuropsychiatric disorders.
No. 2 Late-Stage Session
The Late-Stage Session Executives from Daiichi Sankyo, Takeda, Boehringer Ingelheim, and Thermo Fisher Scientific discussed the global innovation ecosystem and emerging industry trends.
Key Takeaways:
Innovation must remain grounded in strong science, robust biology, high-quality data, and rigorous R&D.
China and AI are long-term structural forces rather than short-term trends. Companies need a clear and coherent China strategy.
AI can support the full R&D value chain, but it cannot replace scientific fundamentals.
The session also featured presentations from HighTide Therapeutics, Constimulus Bio, CanWell Pharma, Jiangsu Chia Tai Fenghai Pharmaceutical, Amphiprotech, and VyBio, showcasing advanced pipelines and global development opportunities across multiple therapeutic areas.
About ACROBiosystems Group:
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing innovative products and business models. The company spans across the globe and maintains offices, R&D centers, and production bases in more than 15 different cities within the United States, Switzerland, the United Kingdom and Germany. ACROBiosystems Group has established numerous long-term and stable partnerships with the world's top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics.
ACROBiosystems' brands include Resilient Supply, CytoPak, SAFENSURE, FLAG, Star Staining, Aneuro, ComboX, GENPower and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.
Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and their clinical applications, and contributes to global health.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets with Global Strategic Opportunities
